These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1351044)
41. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Zhang WD; Hirohashi S; Tsuda H; Shimosato Y; Yokota J; Terada M; Sugimura T Jpn J Cancer Res; 1990 Feb; 81(2):108-11. PubMed ID: 1970554 [TBL] [Abstract][Full Text] [Related]
42. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Coles C; Thompson AM; Elder PA; Cohen BB; Mackenzie IM; Cranston G; Chetty U; Mackay J; Macdonald M; Nakamura Y Lancet; 1990 Sep; 336(8718):761-3. PubMed ID: 1976143 [TBL] [Abstract][Full Text] [Related]
43. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer. Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540 [TBL] [Abstract][Full Text] [Related]
45. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526 [TBL] [Abstract][Full Text] [Related]
46. [Molecular analysis of breast cancers: recent developments]. Bièche I; Lidereau R Bull Cancer; 1992; 79(12):1115-33. PubMed ID: 1304832 [TBL] [Abstract][Full Text] [Related]
47. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754 [TBL] [Abstract][Full Text] [Related]
48. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Lu YJ; Birdsall S; Osin P; Gusterson B; Shipley J Genes Chromosomes Cancer; 1997 Nov; 20(3):275-81. PubMed ID: 9365835 [TBL] [Abstract][Full Text] [Related]
49. [Genetic alterations and DNA-based diagnosis in breast cancer]. Matsumoto S; Emi M; Kasumi F; Nakamura Y Nihon Geka Gakkai Zasshi; 1996 May; 97(5):375-80. PubMed ID: 8709940 [TBL] [Abstract][Full Text] [Related]
50. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Schwerdtle RF; Störkel S; Neuhaus C; Brauch H; Weidt E; Brenner W; Hohenfellner R; Huber C; Decker HJ Cancer Res; 1996 Jul; 56(13):2927-30. PubMed ID: 8674042 [TBL] [Abstract][Full Text] [Related]
51. Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood. Devilee P; van den Broek M; Mannens M; Slater R; Cornelisse CJ; Westerveld A; Khan PM Int J Cancer; 1991 Apr; 47(6):817-21. PubMed ID: 1672665 [TBL] [Abstract][Full Text] [Related]
52. Genetic alterations in primary breast cancer. Callahan R Breast Cancer Res Treat; 1989 Jul; 13(3):191-203. PubMed ID: 2667653 [TBL] [Abstract][Full Text] [Related]
53. Allelic loss in ovarian cancer. Yang-Feng TL; Han H; Chen KC; Li SB; Claus EB; Carcangiu ML; Chambers SK; Chambers JT; Schwartz PE Int J Cancer; 1993 Jun; 54(4):546-51. PubMed ID: 8099899 [TBL] [Abstract][Full Text] [Related]
54. Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma. Ali IU; Lidereau R; Callahan R J Natl Cancer Inst; 1989 Dec; 81(23):1815-20. PubMed ID: 2573734 [TBL] [Abstract][Full Text] [Related]
55. Allelotype of human bladder cancer. Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491 [TBL] [Abstract][Full Text] [Related]
56. Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers. Emi M; Matsumoto S; Iida A; Tsukamoto K; Nakata T; Yokota T; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y Breast Cancer; 1997 Dec; 4(4):243-246. PubMed ID: 11091607 [TBL] [Abstract][Full Text] [Related]
57. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465 [TBL] [Abstract][Full Text] [Related]
58. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648 [TBL] [Abstract][Full Text] [Related]
59. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer. Field JK; Neville EM; Stewart MP; Swift A; Liloglou T; Risk JM; Ross H; Gosney JR; Donnelly RJ Br J Cancer; 1996 Dec; 74(12):1968-74. PubMed ID: 8980398 [TBL] [Abstract][Full Text] [Related]
60. Identification of high-risk breast cancer patients from genetic changes of their tumors. Watatani M; Inui H; Nagayama K; Imanishi Y; Nishimura K; Hashimoto Y; Yamauchi E; Hojo T; Kotsuma Y; Yamato M; Matsunami N; Yasutomi M Surg Today; 2000; 30(6):516-22. PubMed ID: 10883462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]